No results for ‘’
FDC Ltd
₹335.90
(1.03%)
Tue, 06 Oct 2026, 05:48 am
Health Technology
Pharmaceuticals: Major
24.5KFDC Enterprise Value (EV)
| Particulars | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Price to earnings ratio | 13.45 | 9.13 | 8.65 | 7.57 | 10.08 | 12.54 | 10.72 | 10.83 | 16.59 | 18.21 | 19.54 | 19.25 | 25.80 | 17.21 | 14.05 | 16.12 | 20.04 | 21.98 | 22.84 | 24.06 |
| Price to book ratio | 3.24 | 1.80 | 1.46 | 1.52 | 2.85 | 3.05 | 2.06 | 2.12 | 2.65 | 2.88 | 3.04 | 2.86 | 3.44 | 2.02 | 2.17 | 2.78 | 2.22 | 2.15 | 3.30 | 2.81 |
| Price to sales ratio | 2.69 | 1.39 | 1.11 | 1.11 | 2.27 | 2.68 | 2.04 | 2.19 | 2.68 | 3.05 | 3.33 | 3.61 | 4.19 | 2.70 | 2.53 | 3.67 | 2.85 | 2.40 | 3.60 | 3.05 |
| Price to cash flow ratio | 16.76 | 9.03 | 5.52 | 7.16 | 8.72 | 14.28 | 9.39 | 10.21 | 13.79 | 19.21 | 17.35 | 22.01 | 24.47 | 22.66 | 11.55 | 22.28 | 23.41 | 23.92 | 28.07 | 17.63 |
| Enterprise value | 923Cr | 581Cr | 543Cr | 646Cr | 1491Cr | 1880Cr | 1181Cr | 1466Cr | 1996Cr | 2411Cr | 2992Cr | 3165Cr | 4050Cr | 2495Cr | 2852Cr | 4314Cr | 3829Cr | 3810Cr | 6516Cr | 5903Cr |
| Enterprise value to EBITDA ratio | 13.63 | 7.02 | 7.34 | 5 | 8.88 | 11.12 | 7.20 | 8.25 | 9.94 | 12.40 | 13.34 | 13.15 | 17.60 | 10.97 | 8.60 | 12.93 | 14.85 | 14.96 | 18.98 | 17.87 |
| Debt to equity ratio | 0.01 | 0.01 | 0.04 | 0.02 | 0.01 | 0.01 | 0.01 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.01 | 0.01 | 0.02 | 0.01 | 0.01 | 0.01 |
| Return on equity % | 26.52 | 21.06 | 17.85 | 21.63 | 31.41 | 26.40 | 20.44 | 20.97 | 16.61 | 16.63 | 16.71 | 16.03 | 13.63 | 12.48 | 16.03 | 18.37 | 11.73 | 9.85 | 14.96 | 12.19 |
FDC Ltd Enterprise Value
The FDC Ltd Enterprise Value is a key financial metric used by investors to evaluate FDC Ltd's valuation, profitability, and overall financial performance. Tracking the FDC Ltd Enterprise Value helps investors understand whether the stock is undervalued, fairly valued, or trading at a premium compared to its historical performance and industry peers.
FDC Ltd (NSE: FDC, BSE: 531599) is currently trading at ₹335.90, with a market capitalization of ₹5463.09Cr. As a leading company in the Health technology sector and Pharmaceuticals: major industry, monitoring the FDC Ltd Enterprise Value is essential for fundamental analysis.
FDC Ltd Enterprise Value Current Value
The current FDC Ltd Enterprise Value stands at 5903Cr.
The FDC Ltd Enterprise Value has declined compared to earlier levels, suggesting improved fundamentals or more attractive valuation.
FDC Ltd Enterprise Value Historical Trend
The FDC Ltd Enterprise Value has shown the following historical trend:
- 2024: 5903Cr
- 2023: 6516Cr
- 2022: 3810Cr
- 2021: 3829Cr
- 2020: 4314Cr
The decline in FDC Ltd Enterprise Value indicates improving financial efficiency or better earnings growth.
What FDC Ltd Enterprise Value Indicates for Investors
The FDC Ltd Enterprise Value plays a crucial role in understanding the company's financial health and valuation.
This ratio is an important metric used in fundamental analysis of FDC Ltd.
FDC Ltd Enterprise Value Analysis Summary
The FDC Ltd Enterprise Value remains a crucial metric for evaluating the company's valuation and financial stability. Investors tracking FDC Ltd Enterprise Value should also monitor related metrics such as P/E, P/B, EV/EBITDA, D/E, and ROE to get a complete fundamental picture.
Regular tracking of FDC Ltd Enterprise Value helps investors make informed decisions based on long-term growth, valuation trends, and financial performance.